Heart-Lung machine registry ends early – no major findings
NCT ID NCT06159517
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This registry studied the safety and performance of the HL 40 heart-lung machine and its temperature probes in 184 patients having heart, chest, or blood vessel surgery. The goal was to see how often the devices worked without failure or caused related side effects. The study was terminated early, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
184 people
The number who actually took part.
- Started
-
Dec 2023
- Finished
-
Apr 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All eligible patients who are connected to the index devices and undergo a cardiac / thoracic / vascular surgery. This includes neonates, infants, adolescents and adults regardless of age and underlying health condition. It also includes elective, urgent and emergent surgeries.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Signed Patient Informed Consent (including emergency approach) * All patients who are connected to extracorporeal circulation using the index devices. Exclusion Criteria: * Pregnancy * Current participation or planned participation in a concurrent drug or interventional medical device study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiac surgery are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, Italy
-
Hospital Universitario Ramón y Cajal
Madrid, Spain
-
Organización Sanitaria Integrada Ezkerraldea-Enkarterri-Cruces (Centro sanitario Hospital Universitario Cruces)
Bilbao, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Pre-Surgery training help frail hearts recover?
- Blood filter attached to Heart-Lung machine aims to stop ticagrelor bleeding
- Heart Fat's tiny messengers: scientists probe particles that may drive cardiac risk
- Can a simple platelet test predict who bleeds after heart surgery?
- Can a smartwatch outperform standard tools in tracking recovery after surgery?
- Wearables guide home prehab for older lung cancer patients